US FDA finds procedural issues at Lupin’s plant in Nagpur
Nagpur: The US Federal Drug Administration (US FDA) found several procedural deficiencies at Lupin Limited’s injectables Unit Two in Nagpur following its inspection on October 17-29, according to the form 483 issued by the drug regulator, reported Moneycontrol. Lupin, in an...
US FDA finds procedural issues at Lupin’s plant in Nagpur
Nagpur: The US Federal Drug Administration (US FDA) found several procedural deficiencies at Lupin Limited’s injectables Unit Two in Nagpur following its inspection on October 17-29, according to the form 483 issued by the drug regulator, reported Moneycontrol. Lupin, in an...
